Erythema multiforme reactions after Pfizer/BioNTech (BNT162b2) and Moderna (mRNA-1273) COVID-19 vaccination: A case series
Elif Karatas, MD,
Ali Nazim, BS,
Parth Patel, MD,
Toral Vaidya, MD, MPH,
George Scott Drew, DO,
Sanober A. Amin, MD, PhD,
Ashley A. Keyes, MD,
Maira Fonseca, MD,
Adnan Mir, MD, PhD,
Caroline P. Halverstam, MD
Affiliations
Elif Karatas, MD
Department of Internal Medicine, Jacobi Medical Center, Albert Einstein College of Medicine, Bronx, New York
Ali Nazim, BS
Ross University School of Medicine, Bridgetown, Barbados
Parth Patel, MD
Division of Dermatology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York
Toral Vaidya, MD, MPH
Department of Dermatology, Weill Cornell Medical College, New York, New York
George Scott Drew, DO
Dermatology Associates of Mid-Ohio, Marion, Ohio
Sanober A. Amin, MD, PhD
Dermatology Solutions, Grapevine, Texas
Ashley A. Keyes, MD
Department of Dermatology, Weill Cornell Medical College, New York, New York
Maira Fonseca, MD
Department of Dermatology, Weill Cornell Medical College, New York, New York
Adnan Mir, MD, PhD
Dermpath Diagnostics, Port Chester, New York
Caroline P. Halverstam, MD
Division of Dermatology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York; Correspondence to: Caroline P. Halverstam, MD, Division of Dermatology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, 3411 Bainbridge Avenue, 2nd Floor, Bronx, NY 10467.